Company: BNRG
Filing Date: 2025-10-01
Form Type: F-3
Source: 0001213900-25-094365
Chunk: 8

Company: Brenmiller Energy Ltd.
Filing Date: 2025-10-01
Form: F-3
Chunk 8
---
 as of September 30, 2025. This number excludes:

| ● | an aggregate of 103,805 Ordinary Shares issuable upon the exercise of outstanding options to purchase Ordinary Shares, at exercise prices ranging between $0.05 to $1,235.5 per Ordinary Share, issued to directors, officers, service providers and employees; and |
| ● | an aggregate of 3,489,795 Ordinary Shares issuable                                                                                                                                                                                                                  
 upon the exercise of outstanding warrants to purchase Ordinary Shares, at exercise prices ranging between $2.09 to $83.3 per Ordinary                                                                                                                               
 Share, issued to certain investors in connection with private placements and public offerings (including the Ordinary Shares issuable                                                                                                                               
 upon the exercise of Ordinary Warrants).                                                                                                                                                                                                                            |
| ● | an aggregate of 1,660,839 Ordinary Shares issuable                                                                                                                                                                                                                  
 upon the conversion of 3,800 Preferred Shares, with a conversion price of $2.288 per share.                                                                                                                                                                         |
| ● | the effect of the “full-ratchet” anti-dilution adjustment                                                                                                                                                                                                           
 of the conversion price of our outstanding Preferred Shares and warrants.                                                                                                                                                                                           |

<div align='center'>3

RISK FACTORS</div>

Investing in our securities involves risks. Please carefully consider the risk factors described below and those contained in our periodic reports filed with the Securities and Exchange Commission, or SEC, including those set forth under the caption “Summary Risk Factors” and “Item 3. Key Information – D. Risk Factors” in our 2024 Annual Report, which is incorporated by reference into this prospectus. Before making an investment decision, you should carefully consider these risks as well as other information we include or incorporate by reference in this prospectus. You should be able to bear a complete loss of your investment.

<div align='center'>Risks Related to this Offering and Our Ordinary Shares</div>

There can be no assurance that we will be able to maintain continued Nasdaq listing criteria.

On August 12, 2024, we received
a written notice from the Nasdaq Stock Market indicating that we are not in compliance with the minimum bid price requirement for continued
listing set forth in Nasdaq Listing Rule 5550(a)(2), which requires listed securities to maintain a minimum bid price of $1.00 per share.
Under Nasdaq Listing Rule 5810(c)(3)(A), we were granted a grace period of 180 calendar days to regain compliance with the minimum bid
price requirement. On